Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-19-006715
Filing Date
2019-12-06
Accepted
2019-12-06 16:02:27
Documents
2
Effectiveness Date
2019-12-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2240239zdefa14a.htm DEFA14A 29150
2 G875589.JPG g875589.jpg GRAPHIC 9294
  Complete submission text file 0001047469-19-006715.txt   43153
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37686 | Film No.: 191273110
SIC: 2834 Pharmaceutical Preparations